Loading
Life sciences · Observational Study
ClinicalTrials.gov · September 23, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Observational Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07040202). This is a study registration, not published results. Lead sponsor: Institut Pasteur du Cambodge. Recruitment status: RECRUITING. Study type: OBSERVATIONAL. Enrollment: 240 participants (ESTIMATED). Conditions: Dengue, Sepsis, Influenza. Primary outcome measures: Percentage of low density neutrophils in mild/moderate vs severe dengue , From enrollment to study day 3; Mean florescence intensity of neutrophils expressing spleen tyrosine kinase , From enrollment to study day 3.; Serum level of myeloperoxidase in mild/moderate versus severe dengue. , Enrollment to study day 3. Brief summary: The goal of this research study is to help the investigators better understand serious dengue disease. The investigators will collect clinical information and up to four blood samples from participants with dengue, influenza, sepsis, or healthy people. The investigators will perform multiple analyses on the blood samples and compare results between dengue patients and those with influenza or sepsis and healthy people.